1.Analysis of HLA-DQB1 polymorphism for patients with allergic rhinitis of Uygur and Han people in Xinjiang.
Zhongtao CUI ; Hua ZHANG ; Yunlian LIU ; Yuping YANG ; Yangbing XIANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(14):645-648
OBJECTIVE:
To investigate the association of HLA-DQB1 alleles and artemisia pollen allergic patients of Han and Uygur people in the Xinjiang area.
METHOD:
PCR-SSP (sequence-specific primer polymerase chain reaction) were used to test fifty Uygur and fifty Han people with allergic rhinitis with hypersensitivity to artemisia pollen in the Xinjiang area. Fifty normal Uygur and fifty normal Han people in the Xinjiang region were enrolled in the control group.
RESULT:
The frequency of HLA-DQB1 * 05 in the Uygur group with allergic rhinitis was significantly higher (19.4%) than that in the Uygur control group (7%) (P < 0.05). There were no significant difference between in the allergic rhinitis group and in the control group.
CONCLUSION
HLA-DQB1 * 05 might be the susceptibility genes of the Uygur patients with allergic rhinitis in the Xinjiang area.
Adolescent
;
Adult
;
Alleles
;
Asian Continental Ancestry Group
;
genetics
;
Case-Control Studies
;
Ethnic Groups
;
Female
;
Gene Frequency
;
HLA-DQ beta-Chains
;
genetics
;
Humans
;
Male
;
Middle Aged
;
Polymorphism, Genetic
;
Rhinitis, Allergic, Seasonal
;
genetics
;
Young Adult
2.Clinical analysis of 30 cases of cutaneous adverse reactions to tyrosine kinase inhibitors
Huiling ZHU ; Xiping CHENG ; Weining HUANG ; Xia WANG ; Liuyan WEN ; Hui FAN ; Yangbing ZHANG ; Dehua ZHANG ; Jiaxi HE ; Chunping XIONG ; Jiande HAN
Chinese Journal of Dermatology 2018;51(2):101-105
Objective To investigate the clinical features of cutaneous adverse reactions to tyrosine kinase inhibitors.Methods Thirty patients with cutaneous adverse reactions to tyrosine kinase inhibitors were enrolled from the First Affiliated Hospital of Guangzhou Medical University between January 2015 and December 2016,and their laboratory test results,histopathological findings and treatment response data were collected and analyzed retrospectively.Results Of the 30 patients,15 presented with acneiform eruptions,10 with eczematoid eruptions,2 with morbilliform rashes,1 with telangiectasia,1 with hand-foot skin reaction,9 with xerosis,7 with nail changes and 4 with hair changes.A patient with grade 4 acneiform eruptions showed a markedly elevated alanine transaminase (ALT) level (315 U/L).Mild ALT abnormalities (48.5-88.1 U/L) were found in 3 patients with grade 3 acneiform eruptions,1 with grade 2 acneiform eruptions,1 with grade 1 acneiform eruptions and 1 with eczematoid eruptions complicated by fever.Two patients with eczematoid eruptions and 1 with morbilliform rashes showed elevated proportions of peripheral blood eosinophils (0.057-0.303).Pathological changes of the acneiform eruptions included hyperkeratosis and dilation of hair follicles and neutrophilic infiltration.Pathological manifestations of eczematoid eruptions included different degrees of spongiosis,thickened spinous layer,irregular elongation of rete ridges and liquefaction degeneration of basal cells in the epidermis,and perivascular infiltration of lymphocytes and eosinophils in the superficial dermis.Patients with grade 1-3 acneiform eruptions received oral minocycline for 6 weeks,skin lesions gradually regressed,but relapse occurred after the withdrawal.After withdrawal of targeted antineoplastic agents and 2-week treatment with systemic glucocorticoids,skin lesions gradually regressed in patients with grade 4 acneiform eruptions,those with eczematoid eruptions complicated by fever,and those with morbilliform rashes.Skin rashes also resolved in patients with mild morbilliform rashes and those with mild eczematoid eruptions after 2 weeks of treatment with antianaphylactic agents and topical glucocorticoids.Oral antibiotics were effective for the treatment of periungual erythematous swelling or granulomas.Conclusion Tyrosine kinase inhibitor-related cutaneous adverse reactions include a constellation of disorders,and hepatic function can be impaired.
3.Study on the relationship between SNP of CD14 gene and allergic rhinitis in Xinjiang Uygurs and Hans.
Hua ZHANG ; Haifang HU ; Zhilian LIU ; Jie SUN ; Yuping YANG ; Yan WANG ; Guoping TAN ; Yangbing XIANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(23):1076-1080
OBJECTIVE:
This study aimed to investigate the relationship between CD14 gene rs2569192(C/G), rs3138078 (--1359G/T) and allergic rhinitis (AR) in Xinjiang Uygur and Han populations as well as to determine characteristics of polymorphisms.
METHOD:
A total of 300 AR and 300 healthy controls subjects were included. The frequencies of genotypes and alleles were detected as well as the levels of tIgE in different genotypes were compared.
RESULT:
(1) The distribution of genotypes or alleles of CD14 gene rs2569192 (C/G), rs3138078 (--1359G/T) had no differences between the Xinjiang Uygurs and Hans (P > 0.05). The highest frequency of alleles was C, G. (2) The frequencies of genotypes and alleles were not different between the AR and control group in Uygur and Han (P > 0.05). The frequencies of genotypes and alleles of rs2569192 were different between the Uygur AR and Han AR group (P < 0.05). (3) The distribution of genotype frequencies and allele of rs 2569192 in the Xinjiang Uygur and Han population were quite different from Chinese Beijing Han populations, Japanese, European and African (P < 0.05). (4) The serum total IgE level in AR group was higher than that in healthy control group (P < 0.05).
CONCLUSION
(1) rs2569192 (C/G), rs3138078 (--1359G/T) polymorphisms were not different between the Chinese Xinjiang Uygur and Han population. The major allele were both C and G. rs2569192 of CD14 in Xinjiang populations was different from that in the other populations. (2) No relationship between rs2569192, rs3138078 and AR was found. (3) The serum total IgE level in AR group was higher than that in healthy control group. No relationship between CD14 two SNP and serum total IgE level was found.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Alleles
;
Case-Control Studies
;
Child
;
Child, Preschool
;
China
;
epidemiology
;
Ethnic Groups
;
genetics
;
Female
;
Gene Frequency
;
Genotype
;
Humans
;
Hypersensitivity
;
epidemiology
;
genetics
;
Lipopolysaccharide Receptors
;
genetics
;
Male
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Rhinitis
;
epidemiology
;
genetics
;
Young Adult
4.Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation.
Xiaojun LIU ; Shuguang JIANG ; Chongyun FANG ; Hua LI ; Xuhua ZHANG ; Fuqin ZHANG ; Carl H JUNE ; Yangbing ZHAO
Protein & Cell 2017;8(7):514-526
The generation of T cells with maximal anti-tumor activities will significantly impact the field of T-cell-based adoptive immunotherapy. In this report, we found that OKT3/IL-2-stimulated T cells were phenotypically more heterogeneous, with enhanced anti-tumor activity in vitro and when locally administered in a solid tumor mouse model. To further improve the OKT3/IL-2-based T cell manufacturing procedure, we developed a novel T cell stimulation and expansion method in which peripheral blood mononuclear cells were electroporated with mRNA encoding a chimeric membrane protein consisting of a single-chain variable fragment against CD3 and the intracellular domains of CD28 and 4-1BB (OKT3-28BB). The expanded T cells were phenotypically and functionally similar to T cells expanded by OKT3/IL-2. Moreover, co-electroporation of CD86 and 4-1BBL could further change the phenotype and enhance the in vivo anti-tumor activity. Although T cells expanded by the co-electroporation of OKT3-28BB with CD86 and 4-1BBL showed an increased central memory phenotype, the T cells still maintained tumor lytic activities as potent as those of OKT3/IL-2 or OKT3-28BB-stimulated T cells. In different tumor mouse models, T cells expanded by OKT3-28BB RNA electroporation showed anti-tumor activities superior to those of OKT3/IL-2 T cells. Hence, T cells with both a less differentiated phenotype and potent tumor killing ability can be generated by RNA electroporation, and this T cell manufacturing procedure can be further optimized by simply co-delivering other splices of RNA, thus providing a simple and cost-effective method for generating high-quality T cells for adoptive immunotherapy.
Animals
;
CD28 Antigens
;
genetics
;
immunology
;
Electroporation
;
Humans
;
Immunity, Cellular
;
Interleukin-2
;
immunology
;
K562 Cells
;
Mice
;
Muromonab-CD3
;
immunology
;
Neoplasms, Experimental
;
genetics
;
immunology
;
pathology
;
RNA, Messenger
;
genetics
;
immunology
;
T-Lymphocytes
;
immunology
;
Tumor Necrosis Factor Receptor Superfamily, Member 9
;
genetics
;
immunology